Cargando…

Involvement of Gut Microbiota in SLE and Lupus Nephritis

Lupus nephritis is a severe manifestation of systemic lupus erythematosus (SLE). It is caused by immune dysregulation and kidney inflammation. In recent findings, gut microbiota potentially acts as primary mediators to enhance immune complex deposition, complement activation, and macrophage infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohd, Rozita, Chin, Siok-Fong, Shaharir, Syahrul Sazliyana, Cham, Qin Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045095/ https://www.ncbi.nlm.nih.gov/pubmed/36979632 http://dx.doi.org/10.3390/biomedicines11030653

Ejemplares similares

Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2016)

Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2021)

Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2019)

Frequency and Clinical Significance of Elevated IgG4 in Rheumatoid Arthritis: A Systematic Review
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL)
por: Ahmad Pouzi, Nur Aqeelah, et al.
Publicado: (2023)

Control of lupus nephritis by changes of gut microbiota
por: Mu, Qinghui, et al.
Publicado: (2017)

The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis
por: Ismail, Endom, et al.
Publicado: (2016)

SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus
por: Smith, Michael A., et al.
Publicado: (2019)

Role of febuxostat in retarding progression of diabetic kidney disease with asymptomatic hyperuricemia: A 6-months open-label, randomized controlled trial
por: Mukri, Mohd Noor Azreey, et al.
Publicado: (2018)

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
por: Friebus-Kardash, Justa, et al.
Publicado: (2019)

Metaproteomic analysis of human gut microbiota: where are we heading?
por: Lee, Pey Yee, et al.
Publicado: (2017)

Decoding the Clinical Significance of Immunoglobulin G4 in Rheumatoid Arthritis
por: Tan, Li Fen, et al.
Publicado: (2023)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
por: Natoli, Valentina, et al.
Publicado: (2023)

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis
por: Dieker, Jürgen, et al.
Publicado: (2016)

MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654
por: Tu, Yang, et al.
Publicado: (2019)

Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

SLE presenting as migratory arthritis, chorea and nephritis
por: Ajmani, Sajal, et al.
Publicado: (2018)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

Gut dysbiosis is associated with acceleration of lupus nephritis
por: Valiente, Giancarlo R., et al.
Publicado: (2022)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives
por: Toumi, Eya, et al.
Publicado: (2023)

Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN)
por: Williams-Hall, Rebecca, et al.
Publicado: (2022)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Lupus nephritis is associated with poor pregnancy outcomes in pregnant SLE patients in Cape Town: a retrospective analysis
por: Mbuli, Lindisa, et al.
Publicado: (2015)

SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis
por: Itotagawa, Eri, et al.
Publicado: (2022)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis
por: Honarpisheh, Mohsen, et al.
Publicado: (2018)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)

Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies
por: Haselmayer, Philipp, et al.
Publicado: (2014)

Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis
por: Boedigheimer, Michael J, et al.
Publicado: (2017)

Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE
por: Li, Chunzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_amicea0uu8b1so7tndq6aolavh